Neurodegeneration – News and Features
News
Genzyme Acquires Avigen's Gene Therapy Technology
The acquired assets will support and diversify Genzyme's gene therapy research program.
News
New Report Calls for Coordinated European Strategy to Deliver new Medical Tools
The report concludes that nanomedicine is about to deliver a healthcare paradigm shift
News
Scientists Close in on Genes Responsible for Parkinson’s Disease
Findings could help doctors predict the likelihood of the disease developing, and provide targets for new treatments.
News
Nanosphere Awarded U.S. Patent for Biobarcode™ Protein Detection Technology
Biobarcode™ technology is designed for protein detection, for nucleic acid detection and genomics.
News
Celera Diagnostics Discovers Genes Associated with Alzheimer's Disease
The study provides valuable insights into the genetic contribution to Alzheimer's disease.
News
Galapagos Subsidiary BioFocus Collaborate with Senexis
The collaboration aims to significantly advance Senexis' small molecule Alzheimer's programs.
News
Researchers Reveals How Certain Chemicals Protect the Brain Against Cell Damage
Study shows that PGE2 offers some protection against neurotoxicity, linked to stimulation of receptors EP2 and EP4.
News
Neurome Announces Broadened Collaboration With Wyeth
Neurome will evaluate the effectiveness of possible drug candidates.
News
Results Show Potential for Gene Therapy Treatment of Huntington's Disease
Findings show that the gene XIAP may prevent the progression of Huntington's disease.
News
Statins May Slow the Effects of Alzheimer's Disease
Nymox has Global Patent Rights for Statin Drugs for the Treatment and Prevention of Alzheimer's Disease.
Advertisement
